Elanix Biotechnologies AG Logo

Elanix Biotechnologies AG

Develops products from progenitor cells for wound care and dermatological applications.

ELN | F

Overview

Corporate Details

ISIN(s):
DE000A0WMJQ4
LEI:
391200SYNFFL0NPAJK90
Country:
Germany
Address:
Hanauer Landstrasse 291, 60314 Frankfurt am Main

Description

Elanix Biotechnologies AG is a tissue regeneration company that develops and commercializes products for acute wound care, dermatological, and gynecological applications. The company's core focus is on creating therapeutic solutions derived from progenitor cells. Its product development pipeline aims to provide advanced treatments for skin and tissue repair.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2018-11-29 13:00 English 13.8 KB
2018-11-23 22:34
Elanix Biotechnologies AG: Professor Laurent-Applegate, founder and Interim-CEO…
English 6.1 KB
2018-11-12 16:49
Elanix Biotechnologies AG: Frau Prof. Lee Ann Laurent-Applegate wird neuer Vors…
German 7.3 KB
2018-11-12 14:12
Elanix Biotechnologies AG: Widerruf der Bestellung von Herrn Tomas J. Svoboda …
German 6.6 KB
2018-10-01 11:08
Elanix Biotechnologies AG: Elanix Biotechnologies AG has placed 301,763 shares …
English 11.0 KB
2018-09-28 09:47
Release according to Article 41 of the WpHG [the German Securities Trading Act]…
English 4.0 KB
2018-08-09 08:00
Elanix Biotechnologies AG getting confirmation of Outperform Recommendation by …
English 11.9 KB
2018-07-24 21:45
Elanix Biotechnologies AG announces cash capital increase with indirect subscri…
English 11.7 KB
2018-07-24 13:16
Elanix Biotechnologies AG beschliet unter Ausnutzung des Genehmigten Kapitals e…
German 12.8 KB
2018-07-03 18:43
Release according to Article 41 of the WpHG [the German Securities Trading Act]…
English 4.0 KB
2018-06-11 08:31
Elanix Biotechnologies AG: Elanix Biotechnologies AG has placed all 679,920 sha…
English 10.4 KB
2018-05-29 08:00
Elanix Biotechnologies AG: Elanix Biotechnologies AG Strengthens Executive Team…
English 7.2 KB
2018-05-28 13:43
Elanix Biotechnologies AG resolves a capital increase of up to 10 percent with …
English 10.7 KB
2018-05-23 08:00
Elanix Biotechnologies AG: Elanix Biotechnologies AG strengthens its sales netw…
English 8.6 KB
2018-04-30 21:00
Elanix Biotechnologies Raises up to 2.5 Million EUR Through Standby Equity Dis…
English 9.3 KB

Automate Your Workflow. Get a real-time feed of all Elanix Biotechnologies AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Elanix Biotechnologies AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Elanix Biotechnologies AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.